Equities research analysts at StockNews.com began coverage on shares of Fresenius Medical Care AG & Co. KGaA (NYSE:FMS – Get Rating) in a note issued to investors on Saturday. The firm set a "hold" rating on the stock.

FMS has been the topic of several other reports. DZ Bank cut shares of Fresenius Medical Care AG & Co. KGaA from a "buy" rating to a "hold" rating in a research report on Friday, July 29th. JPMorgan Chase & Co. cut their price objective on shares of Fresenius Medical Care AG & Co. KGaA from €51.00 ($52.04) to €23.00 ($23.47) in a research report on Monday, August 1st. Truist Financial lowered their price target on shares of Fresenius Medical Care AG & Co. KGaA from $34.00 to $27.00 and set a "hold" rating on the stock in a research note on Wednesday, June 22nd. Berenberg Bank lowered their price objective on shares of Fresenius Medical Care AG & Co. KGaA from €76.70 ($78.27) to €57.95 ($59.13) in a research note on Wednesday, August 10th. Finally, Jefferies Financial Group raised shares of Fresenius Medical Care AG & Co. KGaA from an "underperform" rating to a "buy" rating and lifted their target price for the stock from $30.30 to $33.70 in a report on Monday, June 27th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, Fresenius Medical Care AG & Co. KGaA has a consensus rating of "Hold" and a consensus target price of $45.83.

Fresenius Medical Care AG & Co. KGaA Trading Down 4.4 %

FMS opened at $14.39 on Friday. The stock has a market capitalization of $8.43 billion, a P/E ratio of 9.17, a P/E/G ratio of 0.77 and a beta of 1.03. Fresenius Medical Care AG & Co. KGaA has a 12 month low of $14.16 and a 12 month high of $36.08. The firm's fifty day simple moving average is $18.35 and its 200 day simple moving average is $25.81. The company has a current ratio of 1.18, a quick ratio of 0.85 and a debt-to-equity ratio of 0.47.

Institutional Trading of Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co. KGaA Company Profile

(Get Rating)

Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Further Reading

• Get a free copy of the StockNews.com research report on Fresenius Medical Care AG & Co. KGaA (FMS)
• MarketBeat: Week in Review 9/19 – 9/23
• Why Does Tesla Stock Remain Resilient?
• Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
• 2 Semiconductor Stocks To Watch For Reversals
• Is Costco's Post-Earnings Price Weakness A Good Time To Buy?

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.